Related Experiment Video
Updated: Sep 26, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Effects of phentolamine on tissue perfusion in pediatric cardiac surgery
1Department of Anaesthesiology and Intensive Care, Cardiology Institute of Istanbul University, Turkey.
Insights
Phentolamine administration during cardiopulmonary bypass (CPB) in pediatric heart surgery reduced lactate levels and improved body perfusion. This suggests phentolamine can mitigate CPB
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Pharmacology
Background:
- Cardiopulmonary bypass (CPB) can cause adverse effects in pediatric patients with congenital heart disease.
- Pharmacologic vasodilation may offer a strategy to mitigate these effects.
Purpose of the Study:
- To assess if phentolamine-induced vasodilation can counteract the detrimental effects of CPB in pediatric patients undergoing cardiac surgery.
- To evaluate the impact of phentolamine on metabolic and perfusion parameters during and after CPB.
Main Methods:
- Prospective, randomized clinical study involving 43 pediatric patients with congenital heart disease.
- Patients received either phentolamine during CPB (Group 1, n=22) or no phentolamine (Group 2, n=21).
- Measurements included temperature gradients and serum lactate levels before, during, and after CPB; systemic oxygen consumption was also assessed.
Main Results:
- Phentolamine group showed significantly lower lactate levels post-CPB and at operation end (p < 0.05).
- Improved central-peripheral temperature uniformity was observed in the phentolamine group during and after CPB (p < 0.05).
- Systemic oxygen consumption was higher in the phentolamine group post-rewarming (p < 0.05), though mean arterial pressure was lower post-CPB (p = 0.03).
Conclusions:
- Phentolamine administration during CPB in pediatric cardiac surgery is associated with reduced anaerobic metabolism.
- Phentolamine appears to promote more uniform body perfusion in this patient population.
- The findings suggest phentolamine is a potential adjunct for managing CPB-related complications in pediatric congenital heart disease surgery.
Objective:
To evaluate whether the deleterious effects of cardiopulmonary bypass (CPB) can be overcome by phentolamine-induced pharmacologic vasodilation in pediatric patients with congenital heart disease.
Design:
Prospective, randomized, clinical study.
Setting:
Single university hospital.
Participants:
Forty-three pediatric patients undergoing open cardiac surgery for repair of congenital heart disease.
Interventions:
Patients were randomly allocated into two groups. Patients in group 1 (n = 22) received 0.2 mg/kg of phentolamine during the cooling and rewarming periods of CPB. Group 2 patients (n = 21) did not receive phentolamine. Temperature measurements (rectal [R], nasopharyngeal [N], and toe [P]) and serum lactate values were obtained before, during, and after CPB; systemic oxygen consumption was evaluated during CPB.
Measurements And Main Results:
At the end of the CPB period and at the end of the operation, lactate values of group 1 (1.87+/-0.37 and 1.8+/-0.39 mmol/L, respectively) were significantly lower than values of group 2 (2.24+/-0.28 and 2.33+/-0.33 mmol/L; p < 0.05 and p < 0.05, respectively). At the beginning of the rewarming period N-R temperature gradients of group 1 (0.14 degrees C+/-0.92 degrees C) were lower than group 2 (-0.58 degrees C+/-1.84 degrees C) values (p < 0.05). Central-peripheral temperature gradients of group 1 obtained at the end of the CPB period (N-R = 2.18 degrees C+/-0.69 degrees C; N-P = 7.84 degrees C+/-1.54 degrees C; R-P = 5.66 degrees C+/-1.70 degrees C) were significantly lower than the values of group 2 (N-R = 2.80 degrees C+/-0.91 degrees C, N-P = 9.97 degrees C+/-2.02 degrees C; R-P = 7.18 degrees C+/-2.10 degrees C; p < 0.05; p < 0.001; p < 0.05). At the end of the operation values of group 1 (N-R = 0.48 degrees C+/-0.31 degrees C; N-P = 6.30 degrees C+/-1.23 degrees C; R-P = 5.82 degrees C+/-1.16 degrees C) were significantly lower than the values of group 2 (N-R = 0.94 degrees C+/-0.56 degrees C; N-P = 8.69 degrees C+/-0.28 degrees C; R-P = 7.75 degrees C+/-2.15 degrees C; p < 0.05; p < 0.001; p < 0.001). The systemic oxygen consumption values of group 1 were higher than group 2 (6.26+/-1.82 v 5.17+/-1.05 mL/min/kg; p < 0.05) after complete rewarming. Mean arterial pressure (MAP) values of group 1 (58.9+/-6.4 mmHg) were lower than group 2 (63.4+/-6.7 mmHg) at the period after CPB (p = 0.03).
Conclusion:
The results suggest that the use of phentolamine during CPB is associated with limited systemic anaerobic metabolism and more uniform body perfusion.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Cardiac Catheterization IV: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management

